Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
about
Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target AntigenPrecision glycocalyx editing as a strategy for cancer immunotherapy.Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1.Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.
P2860
Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Therapeutic antibodies: their ...... hey induce in toxicity studies
@ast
Therapeutic antibodies: their ...... hey induce in toxicity studies
@en
Therapeutic antibodies: their ...... hey induce in toxicity studies
@nl
type
label
Therapeutic antibodies: their ...... hey induce in toxicity studies
@ast
Therapeutic antibodies: their ...... hey induce in toxicity studies
@en
Therapeutic antibodies: their ...... hey induce in toxicity studies
@nl
prefLabel
Therapeutic antibodies: their ...... hey induce in toxicity studies
@ast
Therapeutic antibodies: their ...... hey induce in toxicity studies
@en
Therapeutic antibodies: their ...... hey induce in toxicity studies
@nl
P2093
P2860
P3181
P356
P1476
Therapeutic antibodies: their ...... hey induce in toxicity studies
@en
P2093
Atsuhiko Kato
Masami Suzuki
P2860
P3181
P356
10.1293/TOX.2015-0031
P407
P577
2015-07-01T00:00:00Z